Patent 12018403 was granted and assigned to Adimab, Llc on June, 2024 by the United States Patent and Trademark Office.
The present invention overcomes the inadequacies inherent in the known methods for generating libraries of antibody-encoding polynucleotides by specifically designing the libraries with directed sequence and length diversity.